Belluscura Ltd Launches Slyde in EU

RNS Number : 2739Y
Tekcapital plc
02 March 2017
 

2 March 2017

Tekcapital plc

("Tekcapital" or the "Company")

 

BELLUSCURA LTD LAUNCHES SLYDE™ IN EU

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Ltd ("Belluscura") has launched its Slyde product in the European Union.

Slyde is a light and compact sled for moving its occupant safely down stairs or over rough ground in the event of an emergency evacuation.  It provides a safe and efficient way to evacuate non-ambulatory individuals from any multi-storey building using the stairways. Slyde folds up and stores in stacks of up to five units in a storage sleeve. The sleeve can be wall-mounted for quick access in key locations.  Slyde is sold in two sizes with a range of accessories designed to safely lower people in the event of an emergency evacuation.

 

Stephen Appelbee, Belluscura's International Director of Global Sales said:

"We are delighted to make this important step towards becoming a truly international medical device company.  Our first product, Slyde, is a good example of Belluscura's mission to provide premium medical device products at affordable prices, and we expect it to be widely adopted by hospitals, schools, hotels and rescue services.  We intend to use the expertise of local distributors in each region, starting in the European Union."

Slyde is already available and selling in the USA.

About Belluscura:

Belluscura Limited is a global medical device company founded in Oxford, England.  Its mission is to make healthcare more affordable for patients and their providers by providing proprietary medical devices across a wide variety of treatment and diagnostic disciplines.  Belluscura's products were originally developed by leading medical device companies or research centres, and with its unique business model it is able to offer these devices at affordable prices. To learn more about Belluscura please visit www.belluscura.com.

Tekcapital owns approximately 65% of the share capital of Belluscura.

 

 

For further information, please contact:

 

Tekcapital Plc

 

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

+44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 1293 517744

David Poutney / James Serjeant

 

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

 

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKDFEALXEFF

Companies

Tekcapital (TEK)
UK 100

Latest directors dealings